Castle Biosciences Recognized for Skin Cancer Diagnostics Innovation in 2021 MedTech Breakthrough Awards Program
Share Article LOS ANGELES (PRWEB) May 06, 2021
MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, has been selected as the winner of the “Best New Technology Solution for Oncology” award in the fifth annual MedTech Breakthrough Awards program, recognizing Castle’s DecisionDx®-SCC and DecisionDx® DiffDx™-Melanoma solutions.
Castle Biosciences innovative genomic skin cancer testing technology harnesses information from individual patients’ tumor biology to inform management decisions and i